Anna Alperovich

444 total citations
10 papers, 42 citations indexed

About

Anna Alperovich is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Anna Alperovich has authored 10 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Anna Alperovich's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral-associated cancers and disorders (2 papers). Anna Alperovich is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral-associated cancers and disorders (2 papers). Anna Alperovich collaborates with scholars based in United States, China and Netherlands. Anna Alperovich's co-authors include Anas Younes, Sergio Giralt, Michael Scordo, Jaap Jan Boelens, Jacob D. Soumerai, Parastoo B. Dahi, Gunjan L. Shah, Josel D. Ruiz, Andrew D. Zelenetz and Roni Tamari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Pharmacokinetics.

In The Last Decade

Anna Alperovich

8 papers receiving 41 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Alperovich United States	4	27	19	16	8	7	10	42
Joe Sneath Thompson United Kingdom	2	36 1.3×	19 1.0×	12 0.8×	3 0.4×	8 1.1×	3	48
Katya Ahr United States	3	29 1.1×	20 1.1×	16 1.0×	6 0.8×	18 2.6×	4	45
Magda Alexis France	4	33 1.2×	36 1.9×	15 0.9×	18 2.3×	5 0.7×	9	57
Phillip Michaels United States	4	28 1.0×	10 0.5×	13 0.8×	19 2.4×	10 1.4×	12	63
Rodrigo Santucci Silva United States	4	39 1.4×	13 0.7×	37 2.3×	16 2.0×	4 0.6×	7	48
Abderrazak El Yamani France	4	43 1.6×	36 1.9×	28 1.8×	12 1.5×	15 2.1×	6	55
Amanda Gillespie-Twardy United States	4	23 0.9×	23 1.2×	18 1.1×	11 1.4×	5 0.7×	8	45
Sophia Sohoni United States	2	23 0.9×	13 0.7×	27 1.7×	9 1.1×	7 1.0×	3	35
Matthias Seifert Germany	2	26 1.0×	11 0.6×	23 1.4×	6 0.8×	5 0.7×	4	46
Nicole Lucas United States	2	21 0.8×	9 0.5×	18 1.1×	5 0.6×	9 1.3×	6	28

Countries citing papers authored by Anna Alperovich

Since Specialization

Citations

This map shows the geographic impact of Anna Alperovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alperovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alperovich more than expected).

Fields of papers citing papers by Anna Alperovich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Alperovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alperovich. The network helps show where Anna Alperovich may publish in the future.

Co-authorship network of co-authors of Anna Alperovich

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Alperovich. A scholar is included among the top collaborators of Anna Alperovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Alperovich. Anna Alperovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Gribbin, Caitlin, Anna Alperovich, Barbara Ma, et al.. (2025). Real-world assessment of prophylactic anakinra on neurotoxicity after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis. Blood. 146(Supplement 1). 712–712.

Alperovich, Anna, Sebastian Mayer, Adrienne A. Phillips, et al.. (2024). Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma. Blood. 144(Supplement 1). 2351–2351.

Ni, Ai, Jacob D. Soumerai, Anna Alperovich, et al.. (2022). The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma. Leukemia & lymphoma. 63(3). 573–582. 5 indexed citations

Alperovich, Anna, et al.. (2022). Annotation-efficient learning of surgical instrument activity in neurosurgery. SHILAP Revista de lepidopterología. 8(1). 30–33. 1 indexed citations

Shah, Gunjan L., Jaap Jan Boelens, Dean Carlow, et al.. (2021). Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens. Clinical Pharmacokinetics. 61(4). 553–563. 7 indexed citations

Soumerai, Jacob D., Ai Ni, Anna Alperovich, et al.. (2020). Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma. Leukemia & lymphoma. 61(12). 2939–2946. 1 indexed citations

Ni, Ai, Jacob D. Soumerai, Anna Alperovich, et al.. (2017). Natural History of Hypogammaglobulinemia in Patients with Follicular Lymphoma and the Impact of Anti-CD20-Based Therapy. Blood. 130. 4054–4054. 2 indexed citations

Alperovich, Anna & Anas Younes. (2016). Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma. The Cancer Journal. 22(1). 23–26. 21 indexed citations

Kumar, Anita, Zhitao Ying, Anna Alperovich, et al.. (2016). Outcome of Initial Observation in Mantle Cell Lymphoma. Blood. 128(22). 1803–1803. 4 indexed citations

10.

Alperovich, Anna, et al.. (2015). Composite angioimmunoblastic T-cell and diffuse large B-cell lymphoma. Hematology/Oncology and Stem Cell Therapy. 8(3). 136–137. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact